Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)
Clinical trial NCT00081510 · COMPLETED
Trial details
- NCT number
- NCT00081510
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2009-05-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.